National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Key Information
Due Date: January 25, 2027
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Forecasted
Contact Info:
NIBIB_P41@nih.gov
NIBIB P41 Director 2402717701
NIBIB P41 Director 2402717701
Overview
This Notice of Funding Opportunity (NOFO) encourages grant applications for National Centers for Biomedical Imaging and Bioengineering (NCBIB). NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly.
Show More
Additional Info
Posted Date: June 9, 2026
Application Due Date: January 25, 2027
Estimated Award Date: Not Specified
Eligible Applicants:
- Native American tribal organizations (other than Federally recognized tribal governments)
- Special district governments
- For profit organizations other than small businesses
- City or township governments
- Small businesses
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Independent school districts
- State governments
- Others
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments
- Public housing authorities/Indian housing authorities
- Public and State controlled institutions of higher education
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
